- Home
- Free App Analytics
- Riete Registry
Riete Registry app analytics for January 11
Riete Registry
- S & H Medical Science Service SL
- Apple App Store
- Free
- Medical
RIETE app is the application of the RIETE Registry, the largest database on venous thromboembolic disease (VTE, thrombosis and/or pulmonary embolism), in which practicing physicians from more than 20 countries participate.
A tool for healthcare professionals to have at hand and consult the latest advances on VTE, as well as access to interactive graphics, scientific articles, reference guides and training events.
THIS APP IS NOT INTENDED TO PROVIDE MEDICAL ADVICE
All information, content, and material included in the application are only for informational purposes and are not intended to serve as a substitute for medical consultation, diagnosis, and/or treatment by a qualified physician or health care provider.
The information provided through or in this application is for informational purposes only and does not constitute medical, legal, or other professional advice. The health-related information provided through this app is not a substitute for medical advice and must not be used to diagnose or treat health problems or to prescribe medical devices or other remedies.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us
Riete Registry Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for Riete Registry
Rank
No Data Available
Riete Registry Ranking by Country
Counties in which Riete Registry has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Keypoints in Hemostasia
HEART AND BRAIN HEALTHCARE MARKETING SL
Captyva Catalunya
Digital Means S.R.L.
Int. VTE & Cancer Guidelines
Rachid Nouar
Thrombosis Risk Prediction
everywhereIM BV
Riete Registry VS.
January 11, 2025